Skip to main content
. Author manuscript; available in PMC: 2020 Sep 15.
Published in final edited form as: Cancer. 2019 Jun 17;125(18):3139–3146. doi: 10.1002/cncr.32296

TABLE 2.

Treatment

Black, n (%)
(n=666)
White, n (%)
(n=666)
p-value
Breast surgery 0.028
Lumpectomy 340 (51.1%) 378 (56.8%)
Mastectomy 324 (48.6%) 288 (43.2%)
No breast surgery 2 (0.3%) 0 (0)
Axillary surgery <0.001
SLNB 352 (52.9%) 438 (65.8%)
ALND 297 (44.6%) 219 (32.9%)
Axillary sampling 3 (0.5%) 0 (0)
NA 14 (2.1%) 9 (1.4%)
Chemotherapy 0.004
No 234 (35.1%) 282 (42.3%)
Yes 432 (64.9%) 384 (57.7%)
Endocrine therapy <0.001
No 258 (38.7%) 143 (21.5%)
Yes 408 (61.3%) 523 (78.5%)
Radiation therapy 1
No 230 (34.5%) 232 (34.8%)
Yes 422 (63.4%) 431 (64.7%)
NA 14 (2.1%) 3 (0.5%)

Abbreviations: SLNB, sentinel lymph node biopsy; ALND, axillary lymph node dissection; NA, not available